Ignite Creation Date:
2024-05-06 @ 10:22 AM
Last Modification Date:
2024-10-26 @ 12:29 PM
Study NCT ID:
NCT03236233
Status:
COMPLETED
Last Update Posted:
2017-12-21
First Post:
2017-07-24
Brief Title:
A Study to Investigate the Safety and Tolerability of Single and Repeat Doses of PC786
Sponsor:
Pulmocide Ltd
Organization:
Pulmocide Ltd
Study Overview
Official Title:
A Randomised Single-blind Placebo-controlled Dose-escalation Study to Assess the Safety and Tolerability of Single and Repeat Inhaled Doses of PC786 in Healthy Subjects Combined With a Randomised Single-blind Placebo-controlled Parallel Group to Assess the Safety and Tolerability of a Single Dose of Inhaled PC786 in Subjects With Mild Asthma
Status:
COMPLETED
Status Verified Date:
2017-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study investigates the safety tolerability and pharmacokinetics of single and repeat doses of PC786
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2016-000934-22 | EUDRACT_NUMBER | None | None |